Danone Finalizes Full Exit of 22.61% Stake at $19.50/Share; Lifeway to Repurchase $5M
LWAY sits 37% above its 52-week low of $17.31 on elevated volume (3.3× avg).
Summary
Major institutional shareholder Danone is selling its entire 22.61% stake in Lifeway Foods for $67.37 million at a discounted price of $19.50 per share, while Lifeway Foods plans to repurchase up to $5 million of shares.
Key Events · Ownership and Investor Activity · LWAY
-
Major Shareholder Exit Finalized
Danone USA Public Benefit Corporation is selling its entire 22.61% stake, comprising 3,454,756 shares, in Lifeway Foods. This represents a complete divestment by a significant institutional investor.
-
Offering Priced at Significant Discount
The shares are being offered at $19.50 per share, totaling $67.37 million. This price is a substantial discount compared to the stock's last reported sale price of $27.25 on May 13, 2026, and today's price of $23.80.
-
Company Initiates Share Repurchase
Lifeway Foods has agreed to repurchase up to $5 million of its common stock from the underwriter, funded by existing cash. This move aims to offset some of the dilution and potential market pressure from Danone's large sale.
Analysis · LWAY · Manufacturing
This filing finalizes the terms of the secondary offering where Danone USA Public Benefit Corporation is selling its entire 22.61% stake in Lifeway Foods. The offering is priced at $19.50 per share, a significant discount to the stock's closing price of $27.25 on May 13, 2026. While the company will not receive proceeds from Danone's sale, it has agreed to repurchase up to $5 million of shares from the underwriter, a move that could help mitigate some of the selling pressure from this substantial divestment. The complete exit of a major institutional shareholder, especially at a deep discount, is a notable negative signal, despite the company's offsetting repurchase.
At the time of this filing, LWAY was trading at $23.80 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $363.7M. The 52-week trading range was $17.31 to $34.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.